Acquisition in Pharma and Health Care Industry in China

12 March 2017

Leaf team has advised a world leader in the health care sector on the acquisition of several ophtalmic lens manufacturing units in China (legal due diligence, structuring of the transaction as both an equity and asset deal, drafting of intellectual property licence agreement, assignment of employees).

Assisting a world leading pharmaceutical group with the acquisition of the minority equity interests in its joint venture in Shenzhen.